TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/01/2025
Back to search
Official data from USPTO
AXXIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AXXIN
ST13
US500000079323461Class
9, 10, 40, 42, 44
Filing
79323461
Registration
7134872
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
05/08/2025
Trademark type
Word
Nice classes
9, 10, 40, 42, 44
Filing date
06/03/2021
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
05/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
CORNWELL, ANDREA
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Axxin Pty Ltd
Representatives
Jason Paul Blair DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 9Class 10Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Scientific apparatus and instrumentsopticalisothermalchromatographiccardiographicmicrofluidicphotometricchemicalgeneticbiological sensors and instruments for measuring and analyzing molecular reagentsnucleic acid reagentsimmunoassay reagents for scientific testing purposesfor identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applicationsfor testing for specific DNApathogensantigensviruses and bacterianone of the foregoing goods for medical diagnostic or treatment purposes; recorded softwaredownloadable softwarerecorded and downloadable operating system software for controlling or operating and configuring biomedical sensors and instrumentsanalyzing test and sample resultsmanaging assay test workflow and protocol designcompiling and exporting medical test data for scientificdiagnosticmedical treatment purposes; none of the foregoing used in the field of dentistry; none of the aforementioned goods in relation to access control productsvideo intercom productsaudio intercom productssurveillance productscameras including but not limited to digital camerasnetwork camerasweb cameras and ip-camerasvideo encodersvideo decodersnetwork document serversprint serversnetwork video productsradarsspeakersmicrophonessoftware and accessories for the above mentioned goods
Class 10
Biomedical apparatus and instrumentsopticalisothermalchromatographiccardiographicmicrofluidicphotometricchemicalgeneticbiological sensors and instruments for measuring and analyzing molecular reagentsnucleic acid reagentsimmunoassay reagents for medical purposesfor identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applicationsfor testing for specific DNApathogensantigensviruses and bacteria for medical diagnostic or treatment purposes; none of the foregoing used in the field of dentistry
Class 40
Custom manufacture of medical devicesopticalisothermalchromatographiccardiographicmicrofluidicphotometricchemicalgeneticbiological sensorsinstrumentscartridges for measuring and analyzing molecularnucleic acidimmunoassay reagents using in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications for identifying diseases or medical conditionsfor testing for specific DNApathogensantigensviruses and bacteria; informationadvisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistry
Class 42
Design and development of medical devicesopticalisothermalchromatographiccardiographicmicrofluidicphotometricchemicalgeneticbiological sensorsinstrumentscartridges for measuring and analyzing molecular reagentsnucleic acid reagentsimmunoassay reagents for medical purposesfor identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applicationsfor testing for specific DNApathogensantigensviruses and bacteria; design and development of computer hardware and software for controlling or operating and configuring biomedical sensors and instrumentsanalyzing test and sample resultsmanaging assay test workflow and protocol designcompiling and exporting medical test data for scientificdiagnostictreatment purposes; scientific research services; scientific laboratory services; medical researchanalysistesting laboratories; none of the foregoing used in the field of dentistry; none of the aforementioned services in the fields of security surveillance and video surveillance
Class 44
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testing services; informationadvisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistry
Publications
History of USPTO decisions and trademark events.
50 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/01/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/01/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/01/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/15/2023
FIMP
FINAL DISPOSITION PROCESSED
11/15/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/15/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
11/07/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/30/2023
PUBO
PUBLISHED FOR OPPOSITION
05/30/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/25/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/25/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/25/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/25/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/18/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/18/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/22/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/22/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2023
ATRV
ATTORNEY REVIEW COMPLETED
01/19/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
01/12/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/03/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/18/2022
GNFR
FINAL REFUSAL E-MAILED
10/18/2022
CNFR
FINAL REFUSAL WRITTEN
10/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2022
RFNT
REFUSAL PROCESSED BY IB
04/18/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/31/2022
RFRR
REFUSAL PROCESSED BY MPU
03/31/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/01/2022
CNRT
NON-FINAL ACTION WRITTEN
02/28/2022
DOCK
ASSIGNED TO EXAMINER
02/18/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/25/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/22/2021
Continuous trademark protection
Get notified about every new filing that threatens AXXIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.